Pharmacologic treatment to prevent episodic migraine should follow a sequential trial approach that considers medication cost, headache triggers, adherence, and lifestyle interventions.
Maggie L. Shaw
Advertisement
Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Articles by Maggie L. Shaw
New research shows that patients with heart failure who had more steps per day and increasing steps per day experienced better health status over 12 weeks.
Advertisement
Latest Updated Articles
Increased Step Count Tied to Better Health for Patients with Heart FailurePublished: September 6th 2023 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
5 Novel Mechanisms Reshaping Atopic Dermatitis Treatment and the Phase 2-3 Clinical Trials That Support Them
2
Axsome Submits sNDA for AXS-05 to Treat Agitation in Alzheimer Disease
3
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis: Daily Dose
4
CagriSema Reduces SBP by 10.9 mmHg in Post Hoc Analysis of REDEFINE 1 Trial
5
